Cross Protection by Encephalitis Vaccine as a Factor for Lesser COVID Mortality

▴ Cross Protection by Encephalitis Vaccine as a Factor for Lesser COVID Mortality

"As we are not sure when a drug or vaccine will be available to relieve humankind from the clutches of this pandemic, our modest contribution through this hypothesis, we do hope may trigger similar or better thoughtful ideas," said Dr. Katoh.


A significant discrepancy in mortality among even geographically close regions could be explained by a cross protection induced by Japanese Encephalitis Vaccine (JEV) and/or Tick-Borne Encephalitis Vaccine (TEV) according to Dr Shojiro Katoh, President, Edogawa Hospital. He along with his international team of researchers of Edogawa Evolutionary Lab of Science (EELS), have published their opinion in Archives of Academic Emergency Medicine, a peer reviewed journal

The COVID-19 pandemic with 2,478,634 people infected, and 170,000 deaths globally, has caused unprecedented implications on day-to-day life and the global economy. Loss of lives in Spain (20,852) and Italy (24,114) are more than China (4,632), the epicenter of the outbreak, where JEV and/or TEV is included in national immunization schedule, like Japan (186) and Austria (463). In China, the mortality is 2.3% compared to 7.3% in Italy and 10.41% in Spain, where JEV and/or TEV is not routine. JEV immunization is widespread, or in the national vaccination programs of Japan, Laos, Malaysia, Nepal, South Korea, Thailand, Sri Lanka, and Vietnam where the mortality rate is relatively lower than countries that don’t. Going by the above data, cross-protection conferred by the encephalitis vaccine(s) could be thought as a reason for lower mortality, which must be proven by necessary validations. If any such cross protection could be confirmed to be of help even at least for a specific group, especially the vulnerable population such as the elderly and those with co-morbid conditions, may pave way for arriving at efficient strategies for tackling COVID-19.


"As we are not sure when a drug or vaccine will be available to relieve humankind from the clutches of this pandemic, our modest contribution through this hypothesis, we do hope may trigger similar or better thoughtful ideas," said Dr. Katoh.

Tags : #NewInnovation #Covid19 #Pandemic #EncephalitisVaccine

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

Meet Pranav Sharma, Co-founder & Managing Partner, Woodstock Fund on Effect of COVID-19 in Indian economyJune 05, 2020
Meet Ninad Karpe, Partner 100X.VC, on Future of the Indian startupsJune 04, 2020
Dalmia Healthcare starts clinical trial of Astha-15 for COVID-19 treatementJune 04, 2020
Project Baala and Delhi Government to distribute sanitary padsJune 04, 2020
Germany to lift travel warning for Europe June 04, 2020
Anti-Malaria drug hydroxychloroquine's coronavirus trials to resume June 04, 2020
Recovery From COVID-19 Crisis "Reset Moment" For World: Prince CharlesJune 04, 2020
Boris Johnson defends "Test And Trace" SchemeJune 04, 2020
Amazon sued after warehouse worker gets COVID June 04, 2020
Anti-Malaria drug touted by Trump ineffective at preventing COVID-19June 04, 2020
India-Origin UK minister tested for coronavirus June 04, 2020
Gujarat's Naroda BJP MLA tests positiveJune 04, 2020
COVID 19 news update : Haryana,Punjab,Chandigarh,DelhiJune 04, 2020
Cabinet approves Pharmacopoeia Commission for Indian Medicine & HomeopathyJune 04, 2020
NCVTC to develop of host-directed antivirals for COVID 19June 04, 2020
Uttarakhand CM, his three cabinet ministers in self-quarantineJune 04, 2020
Coronavirus cases in Maharashtra up by 2,560. 122 die in one day June 04, 2020
Delhi government serves show-cause notice to private laboratories June 04, 2020
Ayush Kadha at UP government offices while MP applies for clinical trialsJune 04, 2020
WHO restarts HCQ trial on COVID-19 patientsJune 04, 2020